NASDAQ: EIDX - Eidos Therapeutics, Inc.

Yield per half year: +178.07%
Dividend yield: 0.00%
Sector: Healthcare

Reporting Eidos Therapeutics, Inc.

Capitalization

2016 2017 2018 2019 2020 LTM 5 year average CAGR 5
ΠšΠ°ΠΏΠΈΡ‚Π°Π»ΠΈΠ·Π°Ρ†ΠΈΡ, ΠΌΠ»Ρ€Π΄ $
0.3132 1.23 4.75 4.75
Π’Ρ‹Ρ€ΡƒΡ‡ΠΊΠ°, ΠΌΠ»Ρ€Π΄ $
0.027 127 127
Чистая ΠΏΡ€ΠΈΠ±Ρ‹Π»ΡŒ, ΠΌΠ»Ρ€Π΄ $
-0.003 -0.012 -0.041 -0.038 -0.1 -0.101
EV, ΠΌΠ»Ρ€Π΄ $
4.84 4.84
EBIT, ΠΌΠ»Ρ€Π΄ $
-0.0024 -0.012 -0.0377 -0.0374
EBITDA, ΠΌΠ»Ρ€Π΄ $
0 0 0 0 -0.1 -0.1
Баланс ΡΡ‚ΠΎΠΈΠΌΠΎΡΡ‚ΡŒ, ΠΌΠ»Ρ€Π΄ $
-0.0025 -0.0132 0.155 0.1714
FCF, ΠΌΠ»Ρ€Π΄ $
-0.002 -0.01 -0.033 -0.032 -0.086
ΠžΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΎΠ½Π½Ρ‹ΠΉ Π΄Π΅Π½Π΅ΠΆΠ½Ρ‹ΠΉ ΠΏΠΎΡ‚ΠΎΠΊ, ΠΌΠ»Ρ€Π΄ $
-0.0021 -0.0097 -0.0331 -0.0316
ΠžΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΎΠ½Π½Π°Ρ ΠΏΡ€ΠΈΠ±Ρ‹Π»ΡŒ, ΠΌΠ»Ρ€Π΄ $
-0.002 -0.012 -0.038 -0.04 -0.1
ΠžΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΎΠ½Π½Ρ‹Π΅ расходы, ΠΌΠ»Ρ€Π΄ $
0.0024 0.012 0.0378 0.0671
CAPEX, ΠΌΠ»Ρ€Π΄ $
0.0001 0.0001 0.00015 0.000227


Balance sheet

2016 2017 2018 2019 2020 LTM 5 year average CAGR 5
ΠΠ°Π»ΠΈΡ‡Π½ΠΎΡΡ‚ΡŒ, ΠΌΠ»Ρ€Π΄ $
0.002 0.0055 0.1571 0.1912 0.15 0.15
Total Receivables $
0 0.0001 0.0000 0.0001
Total Current Assets $
0.002 0.006 0.159 0.1959
ЧистыС Π°ΠΊΡ‚ΠΈΠ²Ρ‹, ΠΌΠ»Ρ€Π΄ $
0.000114 0.000209 0.0053
Активы, ΠΌΠ»Ρ€Π΄ $
0.002 0.0063 0.1601 0.2038
Short Term Debt $
0.000315
Long Term Debt $
0.000315 0.0161
Π—Π°Π΄ΠΎΠ»ΠΆΠ΅Π½Π½ΠΎΡΡ‚ΡŒ, ΠΌΠ»Ρ€Π΄ $
0.0044 0.0195 0.0051 0.0324
Π”ΠΎΠ»Π³, ΠΌΠ»Ρ€Π΄ $
0.00063 0.02 0.02
Interest income $
0.001 0.000327
Чист. ΠΏΡ€ΠΎΡ†. Π΄ΠΎΡ…ΠΎΠ΄Ρ‹, ΠΌΠ»Ρ€Π΄ $
-0.000327
Π‘Π΅Π±Π΅ΡΡ‚ΠΎΠΈΠΌΠΎΡΡ‚ΡŒ, ΠΌΠ»Ρ€Π΄ $
0.0025


Share

2016 2017 2018 2019 2020 2021 2024 LTM 5 year average CAGR 5
EPS -0.13 -0.61 -1.86 -1.03 -2.65 -2.65
Π¦Π΅Π½Π° Π°ΠΊΡ†ΠΈΠΈ Π°ΠΎ 20 13.76 57.39 131.58 122.21 122.21
Число Π°ΠΊΡ†ΠΈΠΉ Π°ΠΎ, ΠΌΠ»Π½ 3 4 21 37


Efficiency

2016 2017 2018 2019 2020 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROE, % 102.79 90.49 -57.44 -23.18 -70.31 -70.31 29.56
ROA, % -128.71 -287.11 -48.93 -20.79 -35.95 -59.27 9.53
ROIC, % -57.44 -20.33 -62.91 17.65
ROS, % -141.75 -0.0795 -0.0795 -0.0795 -0.0795 -0.0795 23.21
ROCE, % 96.44 91.03 -24.34 -21.83 0 0 35.43
Ebit margin, % 0 0
Π Π΅Π½Ρ‚Π°Π± EBITDA, % 0 -0.0787 -0.0787 31.33
Чистая Ρ€Π΅Π½Ρ‚Π°Π±, % -151.6 -77.05 -77.05 23.20
Operation Margin, % -151.55 -0.0787 -0.0787 -0.0787 -0.0787 27.09
Чистая процСнтная ΠΌΠ°Ρ€ΠΆΠ°, % -141.75 24.17


Coefficients

2016 2018 2019 2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/E
-7.69 -32.42 27.98
P/BV
3.1 13.3 41.7 38.7 7.37
P/S
78.1 37.41 36595.5 6.93
P/FCF
-55.23 -55.23 -55.23 -55.23 37.86
E/P
-0.13 -0.0308 -0.0213 -0.0213 -0.0213 -0.0213 0.04
EV/EBITDA
-49.6 -49.6 22.92
EV/EBIT
0 0 0
EV/S
0.0381 0.0381 0.0381 0.0381 7.21
EV/FCF
-56.28 -56.28 -56.28 41.58
Debt/EBITDA
-0.2 -0.2 -0.2 -0.2 2.20
Netdebt/Ebitda
0 0 0 0 1.12
Debt/Ratio
0.319 0 0 0 0 0.23
Debt/Equity
-0.2548 0 0 0 0 2.64
Debt/Net Income
-0.2478 -0.198 -0.198 -0.198 -0.198 3.19
Π‘Π΅Ρ‚Π°
-0.17 0 0 0 0 0 0 -0.29
ИндСкс ΠΠ»ΡŒΡ‚ΠΌΠ°Π½Π°
0 0 0 0 0 0 -65.39


Dividends

2020 LTM Industry average 5 year average CAGR 5
Π”ΠΈΠ²ΠΈΠ΄Π΅Π½Π΄Ρ‹ / ΠΏΡ€ΠΈΠ±Ρ‹Π»ΡŒ, %
0 0 40.48


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription